Strategies for co-targeting the PI3K/AKT/mTOR pathway in NSCLC
Author:
Publisher
Elsevier BV
Subject
Radiology, Nuclear Medicine and imaging,Oncology,General Medicine
Reference171 articles.
1. Global cancer statistics in the year 2000;Parkin;Lancet Oncol,2001
2. Prognostic assessment after surgical resection for non-small cell lung cancer: experiences in 2083 patients;Pfannschmidt;Lung Cancer,2007
3. New driver mutations in non-small-cell lung cancer;Pao;Lancet Oncol,2011
4. PIK3CA mutations and copy number gains in human lung cancers;Yamamoto;Cancer Res,2008
5. Intermittent administration of MEK inhibitor GDC-0973 plus PI3K inhibitor GDC-0941 triggers robust apoptosis and tumor growth inhibition;Hoeflich;Cancer Res,2012
Cited by 138 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Network Pharmacology Based Elucidation of Molecular Mechanisms of Laoke Formula for Treatment of Advanced Non-Small Cell Lung Cancer;Chinese Journal of Integrative Medicine;2024-06-28
2. Increased expression of REG3A promotes tumorigenic behavior in triple negative breast cancer cells;Breast Cancer Research;2024-06-05
3. Increased expression of REG3A promotes tumorigenic behavior in triple negative breast cancer cells;2024-06-03
4. The potential role of circular RNAs -regulated PI3K signaling in non-small cell lung cancer: Molecular insights and clinical perspective;Pathology - Research and Practice;2024-05
5. Bioinformatics analysis and validation of CSRNP1 as a key prognostic gene in non-small cell lung cancer;Heliyon;2024-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3